<DOC>
	<DOCNO>NCT01071070</DOCNO>
	<brief_summary>Evaluate Safety Efficacy Paricalcitol Reducing Serum Intact Parathyroid Hormone Chronic Kidney Disease</brief_summary>
	<brief_title>Evaluate Safety Efficacy Paricalcitol Reducing Serum Intact Parathyroid Hormone Chronic Kidney Disease</brief_title>
	<detailed_description>Evaluate safety efficacy paricalcitol injection two different dose regimen ( currently approve dose regimen use US package insert versus dose base formula iPTH/80 approve used EU package insert ) Chronic Kidney Disease ( CKD ) Stage 5 subject secondary hyperparathyroidism receive hemodialysis .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Subject Chinese male female great equal 20 year old . 2 . Subject diagnose Chronic Kidney Disease Stage 5 must maintenance hemodialysis three time week least 2 month prior Screening Visit expect remain hemodialysis duration study . 3 . For entry Treatment Phase , subject must : Intact parathyroid hormone great equal 300 pg/mL Serum calcium le 10.2 mg/dL ( 2.55 mmol/L ) Calciumphosphorus product le 65 mg^2/dL^2 1 . Subject history allergic reaction significant sensitivity vitamin D vitamin D related compound . 2 . Subject receive partial parathyroidectomy within one year prior Screening Phase . 3 . Subject New York Heart Association ( NYHA ) Class III IV . 4 . Subject take aluminumcontaining phosphate binder great 3 week last 3 month prior Screening Phase , require medication great 3 week study . 5 . Subject current malignancy ( exception basal squamous cell carcinoma skin ) , clinically significant liver disease , opinion Investigator . 6 . Subject history drug alcohol abuse within 6 month prior Screening Phase . 7 . Subject know human immunodeficiency virus ( HIV ) positive . 8 . Subject evidence poor compliance diet , medication hemodialysis may interfere , Investigator 's opinion , adherence protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Secondary hyperparathyroidism</keyword>
</DOC>